V T DeVita

IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans

J Higginson, V T DeVita · Food and Chemical Toxicology · 1983 · 453 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +14

The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.

Robert C. Young, Daniele Longo, Eli Glatstein et al. · PubMed · 1988 · 313 citations

Medicine, Oncology, Hematologic Oncology +9

The calculation of actual or received dose intensity: a comparison of published methods.

D L Longo, P L Duffey, V T DeVita et al. · Journal of Clinical Oncology · 1991 · 184 citations

Medicine, Oncology, Pharmacology +11

Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.

Antonella Surbone, D L Longo, V T DeVita et al. · Journal of Clinical Oncology · 1988 · 180 citations

Medicine, Hematology, Oncology +14

Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma

R I Fisher, SM Hubbard, V T DeVita et al. · Blood · 1981 · 162 citations · Full text

Veterinary Medicine, Oncology, Pathology +14